An integrated model of immunoregulation mediated by regulatory T cell subsets

Advances in Immunology

Volumn 83, Issue , 2004, Pages 253-288

  Jiang, Hong ^a   Chess, Leonard ^a  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA FRAGMENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BINDING AFFINITY; CELL ACTIVITY; CELL COUNT; CELL DEATH; CELL FUNCTION; CELL SELECTION; CLONAL VARIATION; COLITIS; COMPLEX FORMATION; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; EFFECTOR CELL; ENHANCER REGION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; NATURAL KILLER CELL; NONHUMAN; ONTOGENY; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; TH2 CELL;

EID: 2142707553     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(04)83008-6     Document Type: Article

References (130)

1. Acha-Orbea, H., Mitchell, D. J., Timmermann, L., Wraith, D. C., Tausch, G. S., Waldor, M. K., Zamvil, S. S., McDevitt, H. O., and Steinman, L. (1988). Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54, 263-273.
2. Asherson, G. L., Colizzi, V., and Zembala, M. (1986). An overview of T-suppressor cell circuits. Annu. Rev. Immunol. 4, 37-68.
3. Askenase, P. W., Hayden, B. J., and Gershon, R. K. (1975). Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. Journal of Experimental Medicine 141, 697-702.
4. +CD25+ regulatory T cells suppress NKT cell functions. Cancer Res. 63, 4516-4520.
5. Baxter, A. G., Kinder, S. J., Hammond, K. J., Scollay, R., and Godfrey, D. I. (1997). Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46, 572-582.
6. Ben-Nun, A., Wekerle, H., and Cohen, I. R. (1981). Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 292, 60-61.
7. Benacerraf, B., Greene, M. I., Sy, M. S., and Dorf, M. E. (1982). Suppressor T cell circuits. Annals of the New York Academy of Sciences 392, 300-308.
8. Bendelac, A. (1995). Mouse NK1+ T cells. Curr. Opin. Immunol. 7, 367-374.
9. Bendelac, A., and Fearon, D. T. (1997). Innate pathways that control acquired immunity. Curr. Opin. Immunol. 9, 1-3.
10. Bendelac, A., Lantz, O., Quimby, M. E., Yewdell, J. W., Bennink, J. R., and Brutkiewicz, R. R. (1995). CD1 recognition by mouse NK1+ T lymphocytes. Science 268, 863-865.
11. Bendelac, A., Rivera, M. N., Park, S. H., and Roark, J. H. (1997). Mouse CD1-specific NK1 T cells: Development, specificity, and function. Annu. Rev. Immunol. 15, 535-562.
12. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., and Ochs, H. D. (2001). The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21.
13. Bloom, B. R., Modlin, R. L., and Salgame, P. (1992a). Stigma variations: Observations on suppressor T cells and leprosy. Annu. Rev. Immunol. 10, 453-488.
14. Bloom, B. R., Salgame, P., and Diamond, B. (1992b). Revisiting and revising suppressor T cells. Immunol. Today 13, 131-136.
15. Bouneaud, C., Kourilsky, P., and Bousso, P. (2000). Impact of negative selection on the T cell repertoire reactive to a self-peptide: A large fraction of T cell clones escapes clonal deletion. Immunity 13, 829-840.
16. Boussiotis, V. A., Freeman, G. J., Gribben, J. G., and Nadler, L. M. (1996). The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of, productive immunity, and down-regulation of the immune response. Immunol. Rev. 153, 5-26.
17. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., Wilkinson, J. E., Galas, D., Ziegler, S. F., and Ramsdell, F. (2001). Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73.
18. Burnet, F. M. (1957). A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust. J. Sci. 20.
19. Cantor, H., and Boyse, E. A. (1975a). Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. J. Exp. Med. 141, 1390-1399.
20. Cantor, H., and Boyse, E. A. (1975b). Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J. Exp. Med. 141, 1376-1389.
21. Cantor, H., Hugenberger, J., McVay-Boudreau, L., Eardley, D. D., Kemp, J., Shen, F. W., and Gershon, R. K. (1978a). Immunoregulatory circuits among T-cell sets. Identification of a subpopulation of T-helper cells that induces feedback inhibition. J. Exp. Med. 148, 871-877.
22. Cantor, H., McVay-Boudreau, L., Hugenberger, J., Naidorf, K., Shen, F. W., and Gershon, R. K. (1978b). Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: Absence in NZB mice. J. Exp. Med. 147, 1116-1125.
23. Cantor, H., Shen, F. W., and Boyse, E. A. (1976). Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: After immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J. Exp. Med. 143, 1391-1401.
24. Caux, C., Burdin, N., Galibert, L., Hermann, P., Renard, N., Servet-Delprat, C., and Banchereau, J. (1994). Functional CD40 on B lymphocytes and dendritic cells. [Review] [21 refs]. Res. Immunol. 145, 235-239.
25. Charlton, B., and Lafferty, K. J. (1995). The Th1/Th2 balance in autoimmunity. Curr. Opin. Immunol. 7, 793-798.
26. Chess, L., and Schlossman, S. F. (1977). Human lymphocyte subpopulations. Adv. Immunol. 25, 213-241.
27. + T-cell subsets: Regulation of differentiation and function. [Review] [14 refs]. Res. Immunol. 142, 7-9.
28. Cohen, I. R., and Weiner, H. L. (1988). T-cell vaccination. Immunol. Today 9, 332-335.
29. Connolly, D. J., Cotterill, L. A., Hederer, R. A., Thorpe, C. J., Travers, P. J., McVey, J. H., Dyson, J., and Robinson, P. J. (1993). A cDNA clone encoding the mouse Qa-1a histocompatibility antigen and proposed structure of the putative peptide binding site. J. Immunol. 151, 6089-6098.
30. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M., and Taniguchi, M. (1997). Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623-1626.
31. D'Orazio, T. J., and Niederkorn, J. Y. (1998). A novel role for TGF-beta and IL-10 in the induction of immune privilege. J. Immunol. 160, 2089-2098.
32. Del Prete, G. (1998). The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int. Rev. Immunol. 16, 427-455.
33. Dialynas, D. P., Quan, Z. S., Wall, K. A., Pierres, A., Quintans, J., Loken, M. R., Pierres, M., and Fitch, F. W. (1983). Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131, 2445-2451.
34. Dorf, M. E., and Benacerraf, B. (1984). Suppressor cells and immunoregulation. Ann. Rev. Immunol. 2, 127-158.
35. Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D., and Noelle, R. J. (1994). The role of CD40 in the regulation of humoral and cell-mediated immunity. [Review]. Immunology Today 15, 406-411.
36. Eardley, D. D., Hugenberger, J., McVay-Boudreau, L., Shen, F. W., Gershon, R. K., and Cantor, H. (1978). Immunoregulatory circuits among T-cells sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition. J. Exp. Med. 147, 1106-1115.
37. Eberl, G., Lees, R., Smiley, S. T., Taniguchi, M., Grusby, M. J., and MacDonald, H. R. (1999). Tissue-specific segregation of CD1d-dependent and CD1d-independent NKT cells. J. Immunol. 162, 6410-6419.
38. Ehrlich, P. (1900). The Croonian lecture: On immunity. Proc. Royal Soc., London 66, 424.
39. Evans, R. L., Breard, J. M., Lazarus, H., Schlossman, S. F., and Chess, L. (1977). Detection, isolation, and functional characterization of two human T-cell subclasses bearing unique differentiation antigens. J. Exp. Med. 145, 221-233.
40. Exley, M., Garcia, J., Balk, S. P., and Porcelli, S. (1997). Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells. J. Exp. Med. 186, 109-120.
41. Falcone, M., Yeung, B., Tucker, L., Rodriguez, E., and Sarvetnick, N. (1999). A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J. Exp. Med. 190, 963-972.
42. Fitch, F. W., McKisic, M. D., Lancki, D. W., and Gajewski, T. F. (1993). Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11, 29-48.
43. Frey, A. B., and Rao, T. D. (1999). NKT cell cytokine imbalance in murine diabetes mellitus. Autoimmunity 29, 201-214.
44. Furlan, R., Bergami, A., Cantarella, D., Brambilla, E., Taniguchi, M., Dellabona, P., Casorati, G., and Martino, G. (2003). Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: Critical roles for administration route and IFN-gamma. Eur. J. Immunol. 33, 1830-1838.
45. Gay, D., Maddon, P., Sekaly, R., Talle, M. A., Godfrey, M., Long, E., Goldstein, G., Chess, L., Axel, R., Kappler, J., et al. (1987). Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature 328, 626-629.
46. Germain, R. N., and Benacerraf, B. (1980). Helper and suppressor T cell factors. [Review]. Springer Seminars in Immunopathology 3, 93-127.
47. Gershon, R. K. (1974). T cell control of antibody production. Contemp. Top. Immunobiol. 3, 1-40.
48. Gershon, R. K. (1975). A disquisition on suppressor T cells. Transplant Rev. 26, 170-185.
49. Gershon, R. K. (1976). The role of suppression in immunoregulation. Adv. Exp. Med. Biol. 66, 557-563.
50. Gershon, R. K., and Kondo, K. (1970). Cell interactions in the induction of tolerance: The role of thymic lymphocytes. Immunology 18, 723-737.
51. Gershon, R. K., and Kondo, K. (1971). Infectious immunological tolerance. Immunology 21, 903-914.
52. Gershon, R. K., Mokyr, M. B., and Mitchell, M. S. (1974). Activation of suppressor T cells by tumour cells and specific antibody. Nature 250, 594-596.
53. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J., and Baxter, A. G. (2000). NKT cells: Facts, functions and fallacies. Immunol. Today 21, 573-583.
54. Goldrath, A. W., and Bevan, M. J. (1999). Selecting and maintaining a diverse T-cell repertoire. Nature 402, 255-262.
55. Gombert, J. M., Herbelin, A., Tancrede-Bohin, E., Dy, M., Carnaud, C., and Bach, J. F. (1996). Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol. 26, 2989-2998.
56. Gorelik, L., and Flavell, R. A. (2000). Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171-181.
57. Green, D. R., Flood, P. M., and Gershon, R. K. (1983). Immunoregulatory T-cell pathways. Annu. Rev. Immunol. 1, 439-463.
58. Hammond, K. J., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I., and Baxter, A. G. (1998). Alpha/beta-T cell receptor (TCR)+CD4-CD8-(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187, 1047-1056.
59. Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061.
60. Imani, F., and Soloski, M. J. (1991). Heat shock proteins can regulate expression of the Tla region-encoded class Ib molecule Qa-1. Proc. Natl. Acad. Sci. USA 88, 10475-10479.
61. Janeway, C., Jr., and Bottomly, K. (1994). Signals and signs for lymphocyte responses. [Review]. Cell 76, 275-285.
62. Janeway, C. A., Jr. (1988). Do suppressor T cells exist? A reply [editorial]. Scand. J. Immunol. 27, 621-623.
63. Jenkins, M. K. (1994). The ups and downs of T cell costimulation. Immunity 1, 443-446.
64. Jerne, N. K. (1955). The natural selection theory of antibody formation. PNAS 41, 849.
65. Jerne, N. K. (1975). The immune system: A web of V domains. Harvey Lect 70, 93-110.
66. + T cells in EAE mice. Proc. Natl. Acad. Sci. USA 98, 6301-6306.
67. + T cells restricted by the MHC class IB molecule QA-1. Annu. Rev. Immunol. 18, 185-216.
68. + T cells fine tune the MBP-reactive T cell receptor Vb repertoire during EAE. PNAS 100, 8378-8383.
69. Jiang, H., Kashleva, H., Xu, L. X., Forman, J., Flaherty, L., Pernis, B., Braunstein, N. S., and Chess, L. (1998). T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc. Natl. Acad. Sci. USA 95, 4533-4537.
70. + T cells expressing V beta 8 TCR: A role of the Qa-1 molecule. Immunity 2, 185-194.
71. + T cells in murine experimental allergic encephalomyelitis. Science 256, 1213-1215.
72. Kastner, D. L., Rich, R. R., and Chu, L. (1979). Qa-1-associated antigens. II. Evidence for functional differentiation from H-2K and H-2D antigens. J. Immunol. 123, 1239-1244.
73. + T cells in mice tolerant to Staphylococcus aureus entertoxin B. Nature 349, 245-248.
74. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997). CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278, 1626-1629.
75. +CD25+ T regulatory cells. Nat. Immunol. 4, 337-342.
76. Klaus, S. J., Pinchuk, L. M., Ochs, H. D., Law, C. L., Fanslow, W. C., Armitage, R. J., and Clark, E. A. (1994). Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J. Immunol. 152, 5643-5652.
77. Koh, D.-R., Fung-Leung, W.-P., Ho, A., Gray, D., Acha-Orbea, H., and Mak, T.-W. (1992). Less mortality but more relapses in experimental allergic encephalomyelitis in CD84-/-mice. Science 256, 1210-1213.
78. + T cells. J. Exp. Med. 173, 759-762.
79. Kuchroo, V. K., Anderson, A. C., Waldner, H., Munder, M., Bettelli, E., and Nicholson, L. B. (2002). T cell response in experimental autoimmune encephalomyelitis (EAE): Role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20, 101-123.
80. Kung, P., Goldstein, G., Reinherz, E. L., and Schlossman, S. F. (1979). Monoclonal antibodies defining distinctive human T cell surface antigens. Science 206, 347-349.
81. Lalanne, J. L., Transy, C., Guerin, S., Darche, S., Meulien, P., and Kourilsky, P. (1985). Expression of class I genes in the major histocompatibility complex: Identification of eight distinct mRNAs in DBA/2 mouse liver. Cell 41, 469-478.
82. + T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med. 175, 1091-1101.
83. Lee, P. T., Benlagha, K., Teyton, L., and Bendelac, A. (2002a). Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 195, 637-641.
84. Lee, P. T., Putnam, A., Benlagha, K., Teyton, L., Gottlieb, P. A., and Bendelac, A. (2002b). Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 110, 793-800.
85. Lenardo, M., Chan, K. M., Hornung, F., McFarland, H., Siegel, R., Wang, J., and Zheng, L. (1999). Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment [in process citation]. Annu. Rev. Immunol. 17, 221-253.
86. Lenschow, D. J., Walunas, T. L., and Bluestone, J. A. (1996). CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233-258.
87. Littman, D. R. (1987). The structure of the CD4 and CD8 genes. Annu. Rev. Immunol. 5, 561-584.
88. Littman, D. R., Thomas, Y., Maddon, P. J., Chess, L., and Axel, R. (1985). The isolation and sequence of the gene encoding T8: A molecule defining functional classes of T lymphocytes. Cell 40, 237-246.
89. Maddon, P. J., Littman, D. R., Godfrey, M., Maddon, D. E., Chess, L., and Axel, R. (1985). The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: A new member of the immunoglobulin gene family. Cell 42, 93-104.
90. Maddon, P. J., Molineaux, S. M., Maddon, D. E., Zimmerman, K. A., Godfrey, M., Alt, F. W., Chess, L., and Axel, R. (1987). Structure and expression of the human and mouse T4 genes. Proc. Natl. Acad. Sci. USA 84, 9155-9159.
91. Moller, G. (1988). Do suppressor T cells exist? Scand. J. Immunol. 27, 247-250.
92. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffman, R. L. (1986). Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357.
93. Mosmann, T. R., and Coffman, R. L. (1989). TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173.
94. Nanda, N. K., and Sercarz, E. (1996). A truncated T cell receptor repertoire reveals underlying immunogenicity of an antigenic determinant. J. Exp. Med. 184, 1037-1043.
95. +CD25+ immunoregulatory cells. J. Immunol. 167, 1137-1140.
96. Rao, A., Allard, W. J., Hogan, P. G., Rosenson, R. S., and Cantor, H. (1983). Alloreactive T-cell clones. Ly phenotypes predict both function and specificity for major histocompatibility complex products. Immunogenetics 17, 147-165.
97. Reinherz, E. L., and Schlossman, S. F. (1980). The differentiation and function of human T lymphocytes. Cell 19, 821-827.
98. Roncarolo, M. G., and Levings, M. K. (2000). The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. 12, 676-683.
99. Sakaguchi, S. (2000). Regulatory T cells: Key controllers of immunologic self-tolerance. Cell 101, 455-458.
100. + regulatory T cells that express toll-like receptors. J. Exp. Med. 197, 397-401.
101. Sakaguchi, S., Fukuma, K., Kuribayashi, K., and Masuda, T. (1985). Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161, 72-87.
102. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164.
103. +CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440.
104. Saubermann, L. J., Beck, P., De Jong, Y. P., Pitman, R. S., Ryan, M. S., Kim, H. S., Exley, M., Snapper, S., Balk, S. P., Hagen, S. J., et al. (2000). Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 119, 119-128.
105. Schubert, L. A., Jeffery, E., Zhang, Y., Ramsdell, F., and Ziegler, S. F. (2001). Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276, 37672-37679.
106. Seddon, B., and Mason, D. (1999). Regulatory T cells in the control of autoimmunity: The essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC-cells and CD4(+)CD8(-) thymocytes. J. Exp. Med. 189, 279-288.
107. + T cells. Annu. Rev. Immunol. 12, 635-673.
108. Sharif, S., Arreaza, G. A., Zucker, P., and Delovitch, T. L. (2002). Regulatory natural killer T cells protect against spontaneous and recurrent type 1 diabetes. Ann. N.Y. Acad. Sci. 958, 77-88.
109. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M., Koezuka, Y., Delovitch, T. L., Gombert, J. M., et al. (2001). Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 7, 1057-1062.
110. Shawar, S. M., Vyas, J. M., Rodgers, J. R., and Rich, R. R. (1994). Antigen presentation by major histocompatibility complex class I-B molecules. Annu. Rev. Immunol. 12, 839-880.
111. Shevach, E. M. (2000). Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18, 423-449.
112. + CD25+ suppressor T cells: More questions than answers. Nat. Rev. Immunol. 2, 389-400.
113. + CD25+ suppressor T cells. Immunol. Rev. 182, 58-67.
114. Singh, A. K., Wilson, M. T., Hong, S., Olivares-Villagomez, D., Du, C., Stanic, A. K., Joyce, S., Sriram, S., Koezuka, Y., and Van Kaer, L. (2001). Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1801-1811.
115. Sonoda, K. H., Exley, M., Snapper, S., Balk, S. P., and Stein-Streilein, J. (1999). CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190, 1215-1226.
116. Sonoda, K. H., Faunce, D. E., Taniguchi, M., Exley, M., Balk, S., and Stein-Streilein, J. (2001). NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166, 42-50.
117. Stanton, T. H., and Boyse, E. A. (1979). A new serologically defined locus, Qa-1, in the T1a-region of the mouse. Immunogenetics 3, 525-531.
118. Stanton, T. H., Calkins, C. E., Jandinski, J., Schendel, D. J., Stutman, O., Cantor, H., and Boyse, E. A. (1978). The Qa-1 antigenic system. Relation of Qa-1 phenotypes to lymphocyte sets, mitogen responses, and immune functions. J. Exp. Med. 148, 963-973.
119. Swain, S. L., Dialynas, D. P., Fitch, F. W., and English, M. (1984). Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens. J. Immunol. 132, 1118-1123.
120. Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., and Sakaguchi, S. (2000). Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310.
121. Thomas, Y., Rogozinski, L., and Chess, L. (1983). Relationship between human T cell functional heterogeneity and human T cell surface molecules. Immunol. Rev. 74, 113-128.
122. Thomas, Y., Rogozinski, L., Irigoyen, O. H., Friedman, S. M., Kung, P. C., Goldstein, G., and Chess, L. (1981). Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population. J. Exp. Med. 154, 459-467.
123. Thomas, Y., Rogozinski, L., Irigoyen, O. H., Shen, H. H., Talle, M. A., Goldstein, G., and Chess, L. (1982). Functional analysis of human T cell subsets defined by monoclonal antibodies. V. Suppressor cells within the activated OKT4+ population belong to a distinct subset. J. Immunol. 128, 1386-1390.
124. +CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 164, 183-190.
125. Wilbanks, G. A., and Streilein, J. W. (1990). Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes. Immunology 71, 566-572.
126. Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J. L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001). X-linked neonatal diabetes mellitus, enteropathy, and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18-20.
127. Wilson, S. B., Kent, S. C., Patton, K. T., Orban, T., Jackson, R. A., Exley, M., Porcelli, S., Schatz, D. A., Atkinson, M. A., Balk, S. P., et al. (1998). Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391, 177-181.
128. Wu, J., Wilson, J., He, J., Xiang, L., Schur, P. H., and Mountz, J. D. (1996). Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest. 98, 1107-1113.
129. Zamvil, S., Nelson, P., Trotter, J., Mitchell, D., Knobler, R., Fritz, R., and Steinman, L. (1985). T cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317, 355-358.
130. Zhai, Y., and Kupiec-Weglinski, J. W. (1999). What is the role of regulatory T cells in transplantation tolerance? Curr. Opin. Immunol. 11, 497-503.